Morgan Stanley Set a $300 Price Target on Elon Musk's SpaceX Stock

This is a valuation story disguised as a product story. The market is being asked to capitalize a near-term media event into a multi-decade monetization curve, which is exactly where the biggest dislocations usually appear: the stock can keep trading on narrative momentum long before there is any verifiable cash-flow evidence. That means the cleanest edge is not trying to model terminal TAM, but to separate what can be proven in the next 2-4 quarters from what is effectively a long-dated call option.

Competitive dynamics favor a winner-take-most outcome only if the platform clears a brutal sequence of technical gates. The second-order beneficiaries are likely upstream enablers of the broader AI buildout — launch, payload, semis, and connectivity — rather than the headline stock itself. If investors want AI exposure today, they are still better off in businesses with existing monetization and pricing power than in a speculative orbital infrastructure name with no near-term earnings anchor.

The contrarian risk is that consensus underestimates how long the path from concept to repeatable deployment will take, and how much regulatory, spectrum, launch, and liability friction sits between announcement and revenue. The first real falsifier is not the next promotional update; it is a missed first in-orbit demo, a slip in launch cadence, or a lack of commercial backlog over the next 6-12 months. Until then, implied volatility should remain rich, but that also makes premium-selling structures more attractive than outright stock exposure.